These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6595923)

  • 1. Toward the use of monoclonal antibodies in the analysis of tumor progression and cellular heterogeneity of human breast cancer.
    Nilsson K
    Acta Chir Scand Suppl; 1984; 519():15-8. PubMed ID: 6595923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
    Hand PH; Nuti M; Colcher D; Schlom J
    Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cloning of anti-breast cancer monoclonal antibodies from phage antibody libraries].
    Zhang G; Wang Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):258-62. PubMed ID: 7587890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases.
    Frankfurt OS; Robb JA; Sugarbaker EV; Villa L
    Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a monoclonal antibody to human breast cancer cells.
    Hendler FJ; Yuan D; Vitetta ES
    Trans Assoc Am Physicians; 1981; 94():217-24. PubMed ID: 7344221
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone-resistant breast cancer or "feeding the hand that bites you".
    Horwitz KB
    Prog Clin Biol Res; 1994; 387():29-45. PubMed ID: 7972253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E; Wolf D; Melia M
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of immunohistochemical markers in the diagnosis of carcinoma of the breast].
    Bussolati G
    Minerva Chir; 1988 Sep; 43(18 Suppl):5-7. PubMed ID: 3226595
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
    Kaufmann O; Köther S; Dietel M
    Mod Pathol; 1998 Apr; 11(4):357-63. PubMed ID: 9578086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
    Kuukasjärvi T; Karhu R; Tanner M; Kähkönen M; Schäffer A; Nupponen N; Pennanen S; Kallioniemi A; Kallioniemi OP; Isola J
    Cancer Res; 1997 Apr; 57(8):1597-604. PubMed ID: 9108466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer heterogeneity assessed by flow cytometry.
    Savarese A; Vecchione A
    In Vivo; 1993; 7(6B):631-4. PubMed ID: 8193285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
    Rocha R; Nunes C; Rocha G; Oliveira F; Sanches F; Gobbi H
    Pathol Res Pract; 2008; 204(9):655-62. PubMed ID: 18565685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
    Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
    Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
    Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies.
    Adams DJ; Hajj H; Edwards DP; Bjercke RJ; McGuire WL
    Cancer Res; 1983 Sep; 43(9):4297-301. PubMed ID: 6871865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.